Jay MichaelS.BalagtasMD

Pediatric Hematology & Oncology • Palo Alto, CA

Clinical Associate Professor, Pediatric Hematology/Oncology, Lucile Packard Children's Hospital Stanford

Join to view full profile

Dr. Balagtas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Balagtas' full profile

Already have an account?

Office
725 Welch Rd
Palo Alto, CA 94304
Phone+1 650-497-8953

Fax+1 650-497-8959
Is this information wrong?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Naval Medical Center (San Diego)Residency, Pediatrics, 2003
New York Medical CollegeClass of 1998

Certifications & Licensure

CA State Medical License 2005 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Start of enrollment: 2014 Oct 04
Active, not recruiting
Phase 3
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Active, not recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

9 citations
The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH.
Brian P. Tullius, Uma H. Athale, C. Heleen van Ommen, Anthony K.C. Chan, Joseph S. Palumbo, Jay Michael S. Balagtas> ;Journal of Thrombosis and Haemostasis. 2018 Jan 1
12 citations
Subcutaneous panniculitis-like T-cell lymphoma: Pediatric case series demonstrating heterogeneous presentation and option for watchful waiting.
Emily E. Johnston, Robert E. LeBlanc, Jinah Kim, Jong Hee Chung, Jay Michael S. Balagtas, Youn H. Kim, Michael P. Link> ;Pediatric Blood & Cancer. 2015 Nov 1
4 citations
WARM N COLD: malignant and benign renal tumors in children
Thomas Ray Sanchez, Jonathan M. Ducore, Jay Balagtas, Christopher Molloy, Sandra L. Wootton-Gorges> ;Emergency Radiology. 2014 Feb 26
87 citations
Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types
Craig P. Giacomini, Steven Sun, Sushama Varma, A. Hunter Shain, Marilyn M. Giacomini, Jay Michael S. Balagtas, Robert T. Sweeney, Everett Lai, Catherine A. Del Vecchio...> ;Plos Genetics. 2013 Apr 25
2 citations
Therapeutic complications in a patient with high‐risk acute lymphoblastic leukemia and undiagnosed hereditary hemochromatosis
Jay Michael S. Balagtas, Gary V. Dahl> ;Pediatric Blood & Cancer. 2012 Jan 1
Therapeutic complications in a patient with high-risk acute lymphoblastic leukemia and undiagnosed hereditary hemochromatosis.
Balagtas, J.S., Dahl, G.V.> ;Pediatr Blood Cancer. 2010-11-05
8 citations
Liposomal amphotericin B associated with severe hyperphosphatemia.
Scott M. Sutherland, David K. Hong, Jay Michael S. Balagtas, Kathleen Gutierrez, Christopher C. Dvorak, Minnie M. Sarwal> ;The Pediatric Infectious Disease Journal. 2008 Jan 1
Join now to see all

Hospital Affiliations

Lucile Packard Children's Hospital StanfordPalo Alto, California
Stanford Health CarePalo Alto, California
California Pacific Medical CenterSan Francisco, California
John Muir Medical Center, Walnut CreekWalnut Creek, California